drugset / Trial / NCT03827629

A Study to Compare Bioavailability of Naloxone Nasal Spray and Naloxone Hydrochloride (HCl) Intramuscular Injection (IM) in Healthy Volunteers

NCT03827629

Phase 1 Completed 24 enrolled INSYS Therapeutics Inc
RandomizedCrossoverOpen-labelTreatment

Summary

The main objective of this study is to compare early exposures of two test formulations of Naloxone Nasal Spray with the reference formulation of Naloxone HCl IM Injection under fasted conditions.

Timeline

Start
2017-08-07
Primary completion
2017-08-16
Completion
2017-08-16

Drugs

EvaluationDrugModalityDoseRoute
Subject Naloxone Small molecule Intranasal

Indications

No indication recorded.